HomePASG • NASDAQ
add
Passage Bio Inc
Previous close
$0.67
Year range
$0.45 - $1.79
Market cap
41.38M USD
Avg Volume
1.29M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 15.91M | -31.68% |
Net income | -19.34M | 28.66% |
Net profit margin | — | — |
Earnings per share | -0.24 | 40.59% |
EBITDA | -15.15M | 32.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 84.83M | -36.12% |
Total assets | 111.75M | -33.97% |
Total liabilities | 39.04M | -9.18% |
Total equity | 72.72M | — |
Shares outstanding | 61.77M | — |
Price to book | 0.57 | — |
Return on assets | -33.54% | — |
Return on capital | -36.95% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -19.34M | 28.66% |
Cash from operations | -7.45M | 61.14% |
Cash from investing | 14.97M | -33.33% |
Cash from financing | 0.00 | — |
Net change in cash | 7.52M | 128.77% |
Free cash flow | -2.43M | 79.11% |
About
Founded
2017
Headquarters
Website
Employees
58
